Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

USP10 deubiquitinates RUNX1 and promotes proneural-to-mesenchymal transition in glioblastoma
Wenjin Qiu, Zumu Xiao, Yushi Yang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 16

Showing 16 citing articles:

RUNX transcription factors: biological functions and implications in cancer
Xinyi Chen, Lu Wang, Mu Yang, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
The USP10/13 inhibitor, spautin-1, attenuates the progression of glioblastoma by independently regulating RAF-ERK mediated glycolysis and SKP2.
Swathi V. Kona, Shasi V. Kalivendi
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 7, pp. 167291-167291
Closed Access | Times Cited: 4
Sesquiterpene Lactones as Promising Anti-Glioblastoma Drug Candidates Exerting Complex Effects on Glioblastoma Cell Viability and Proneural–Mesenchymal Transition
Andrey V. Markov, Arseny D. Moralev, Kirill V. Odarenko
Biomedicines (2025) Vol. 13, Iss. 1, pp. 133-133
Open Access
ATXN3 deubiquitinates ZEB1 and facilitates epithelial–mesenchymal transition in glioblastoma
Ruting Wei, Xueping Shi, Wenjin Qiu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
E3 ligases and DUBs target ferroptosis: A potential therapeutic strategy for neurodegenerative diseases
Linxia Lu, Cili Jifu, Jun Xia, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116753-116753
Open Access | Times Cited: 4
USP32 deubiquitinase: cellular functions, regulatory mechanisms, and potential as a cancer therapy target
Shuang Li, Yang Song, Kexin Wang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 8
Proneural-mesenchymal antagonism dominates the patterns of phenotypic heterogeneity in glioblastoma
Harshavardhan BV, Mohit Kumar Jolly
iScience (2024) Vol. 27, Iss. 3, pp. 109184-109184
Open Access | Times Cited: 2
Discovery of Potent Small Molecule Ubiquitin-Specific Protease 10 Inhibitors with Anti-Hepatocellular Carcinoma Activity Through Regulating YAP Expression
Yang Lu, Jian Gao, Peipei Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116468-116468
Closed Access | Times Cited: 2
Subtype Transdifferenziation in Human Cancer: The Power of Tissue Plasticity in Tumor Progression
Monica Fedele, Laura Cerchia, Sabrina Battista
(2024)
Open Access | Times Cited: 1
ecGBMsub: an integrative stacking ensemble model framework based on eccDNA molecular profiling for improving IDH wild-type glioblastoma molecular subtype classification
Ze‐Sheng Li, Wei Cheng, Zhenyu Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Subtype Transdifferentiation in Human Cancer: The Power of Tissue Plasticity in Tumor Progression
Monica Fedele, Laura Cerchia, Sabrina Battista
Cells (2024) Vol. 13, Iss. 4, pp. 350-350
Open Access | Times Cited: 1
Molecular landscapes of glioblastoma cell lines revealed a group of patients that do not benefit from WWOX tumor suppressor expression
Żaneta Kałuzińska‐Kołat, Damian Kołat, Katarzyna Kośla, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 2
NDR1 mediates PD-L1 deubiquitination to promote prostate cancer immune escape via USP10
Huimin Sun, Meiling Fu, Jinxin Li, et al.
Research Square (Research Square) (2024)
Open Access
NDR1 mediates PD-L1 deubiquitination to promote prostate cancer immune escape via USP10
Meiling Fu, Jinxin Li, Zuodong Xuan, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access
RUNX1 regulates MCM2/CDC20 to promote COAD progression modified by deubiquitination of USP31
Wei Tian, Jingyuan Zhao, Xinyu Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
USP10 promotes the progression of triple-negative breast cancer by enhancing the stability of TCF4 protein
Jingru Yang, Yongbin Lu, Hong-xin Su, et al.
Biochemical Pharmacology (2023) Vol. 218, pp. 115864-115864
Closed Access
Page 1

Scroll to top